theory clinical_23_3
imports Main


begin

typedecl entity
typedecl event

consts
  ActivatingMutationCTNNB1 :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  βCatenin :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Via :: "entity ⇒ event ⇒ bool"
  Of :: "entity ⇒ entity ⇒ bool"
  YAPInhibitor :: "entity ⇒ bool"
  Effective :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
axiomatization where
  explanation_1: "∀x y z e. ActivatingMutationCTNNB1 x ∧ Proliferation y ∧ Cell z ∧ βCatenin e ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Via x e ∧ Of y z"

(* Explanation 2: A YAP inhibitor may be effective in inhibiting β-catenin activity. *)
axiomatization where
  explanation_2: "∃x y e. YAPInhibitor x ∧ βCatenin y ∧ Effective e ∧ Inhibit e ∧ Agent e x ∧ Patient e y"


theorem hypothesis:
  assumes asm: "Patient y ∧ ActivatingMutationCTNNB1 z"
  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTTNB1 mutations. *)
  shows "∃x y z e. YAPInhibitor x ∧ Patient y ∧ ActivatingMutationCTNNB1 z ∧ Effective e ∧ Inhibit e ∧ Agent e x ∧ Patient e y"
proof -
  (* From the premise, we know that the patient has activating mutations of CTNNB1. *)
  from asm have "Patient y ∧ ActivatingMutationCTNNB1 z" <ATP>
  (* There is an explanatory sentence stating that activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
  (* We can derive the relation Implies(A, C), Implies(Activating mutations of CTNNB1, via β-catenin). *)
  (* Since we have ActivatingMutationCTNNB1 z, we can infer via β-catenin. *)
  from explanation_1 and ‹ActivatingMutationCTNNB1 z› have "βCatenin e" <ATP>
  (* There is another explanatory sentence stating that a YAP inhibitor may be effective in inhibiting β-catenin activity. *)
  (* We can derive the relation Implies(D, F), Implies(A YAP inhibitor, inhibiting β-catenin activity). *)
  (* Since we have βCatenin e, we can infer A YAP inhibitor. *)
  from explanation_2 and ‹βCatenin e› have "YAPInhibitor x" <ATP>
  (* Combining the information obtained, we can conclude the hypothesis. *)
  then have "YAPInhibitor x ∧ Patient y ∧ ActivatingMutationCTNNB1 z ∧ Effective e ∧ Inhibit e ∧ Agent e x ∧ Patient e y" <ATP>
  then show ?thesis <ATP>
qed

end
